Concepedia

Nataliya Razumilava

NR

Statistics

Publications

16

Citations

1.6K

H-Index

13

Active since

2011

Affiliations

University of Michigan(Current)

Mayo Clinic

Mayo Clinic in Arizona

Virginia Commonwealth University

University of California, San Francisco

Nataliya Razumilava is an author at University of Michigan specializing in medicine, cell biology, and pathology.

ORCID

Top concepts

Publications per year

2011–2022

16

Publications

16

Cholangiocarcinomas can originate from hepatocytes in mice

Biao Fan, Yann Malato, Diego F. Calvisi et al. · Journal of Clinical Investigation · 2012 · 540 citations

, , +14

Biliary repair and carcinogenesis are mediated by IL-33–dependent cholangiocyte proliferation

Jun Li, Nataliya Razumilava, Gregory J. Gores et al. · Journal of Clinical Investigation · 2014 · 197 citations · Full text

, , +20

miR-25 Targets TNF-Related Apoptosis Inducing Ligand (TRAIL) Death Receptor-4 and Promotes Apoptosis Resistance in Cholangiocarcinoma

Nataliya Razumilava, Steve F. Bronk, Rory L. Smoot et al. · Hepatology · 2011 · 191 citations · Full text

IL‐33 facilitates oncogene‐induced cholangiocarcinoma in mice by an interleukin‐6‐sensitive mechanism

Daisaku Yamada, Sumera I. Ilyas, Nataliya Razumilava et al. · Hepatology · 2015 · 138 citations · Full text

Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation

Elise S. Hibdon, Nataliya Razumilava, Theresa M. Keeley et al. · Neoplasia · 2019 · 85 citations · Full text

1–5 of 16